Accessibility Menu
B. Riley Principal 250 Merger logo

B. Riley Principal 250 Merger(NASDAQ) BRIV

This security has been delisted. This page is retained for historical reference.

B. Riley Principal 250 Merger last closing stock price
MetricPriceDate
Last closeUSD 10.192023-05-04
B. Riley Principal 250 Merger stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.15%USD 10.172023-04-27
1 month+0.54%USD 10.132023-04-04
3 month+1.39%USD 10.052023-02-03
Year to date+2.26%USD 9.962022-12-30
1 year+4.25%USD 9.772022-05-04
Since inception+5.76%USD 9.632021-07-06

BRIV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

BRIV Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

3.16%

Return on Capital

-0.68%

Return on Assets

3.10%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$2.08M

Operating Income

-$1.18M

EBITDA

-$1.18M

Operating Cash Flow

-$607.17K

Capital Expenditure

$0.00

Free Cash Flow

-$607.17K

Cash & ST Invst.

$442.98K

Total Debt

$0.00

B. Riley Principal 250 Merger Performance Analysis

B. Riley Principal 250 Merger annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
B. Riley Principal 250 Merger sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12022-03-31N/A
Q22022-06-30N/A
Q32022-09-30N/A
Q42022-12-31N/A
B. Riley Principal 250 Merger annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.01N/A
20222022-12-31USD 0.253172.0%
B. Riley Principal 250 Merger sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12022-03-31286.3%
Q22022-06-30-64.5%
Q32022-09-30-6.0%
Q42022-12-31160.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$1.18M

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$1.62M

+229.1%

EBITDA

-$279.00K

+71.4%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Total Cash

$442.98K

-57.8%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

3.10%

N/A

Return on Invested Capital

-0.68%

N/A

Free Cash Flow

-$70.79K

+21.5%

Operating Cash Flow

-$70.79K

+21.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NGCNorthern Genesis Acquisition Corp. III
$10.16+0.10%
BOACBluescape Opportunities Acquisition Corp.
$10.02-0.09%
BBOTBridgeBio Oncology Therapeutics Inc.
$8.78-2.01%
BIOSBioPlus Acquisition Corp.
$10.80-0.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
TTDThe Trade Desk
$17.67-0.07%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$26.93-0.03%
SPCXSpace Exploration Technologies
$114.92+0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.03-0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.